MET and carcinoma of pharynx: We did not observe such changes upon METi treatment in the pharyngeal carcinoma cell line Detroit 562 (Fig. 1A, Fig. S1A), another MET‐overexpressing cell line displaying HGF‐independent basal MET Y1234&5 phosphorylation, suggesting that METi‐dependent changes occur only in particular MET‐expressing cell lines and correlate well with their sensitivity toward METi and with METi‐induced radiosensitization (Fig. 1B).